Company Profiles

Amryt Pharma DAC

Amryt is a global, commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing novel treatments to help improve the lives of patients with rare and debilitating diseases. Our Mission is to transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those in greatest need.

Mustela

Parents shouldn’t have to choose between caring for their child’s skin and the health of the planet. Because parenting plays a fundamental role in social equilibrium, we work hand-in-hand with parents around the world to bring them natural, effective and healthy products with our B Corp brands: Mustela and Babo Botanicals. We act daily to achieve a lighter ecological footprint, and we have committed our Mustela brand to contribute to global carbon neutrality by 2030.  

LEO Pharma

Sanofi

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.

Pierre Fabre

Pierre Fabre is the 2nd largest dermo-cosmetics laboratory in the world, the 2nd largest private French pharmaceuti-cal group  and  the  market  leader  in  France  for  products  sold over the counter in pharmacies. Its portfolio includes several  medical  franchises  and  international  brands  in-cluding  Pierre  Fabre  Oncology,  Pierre  Fabre  Dermatolo-gy,  Eau  Thermale  Avène,  Klorane,  Ducray,  René  Furterer,  A-Derma, Pierre Fabre Oral Care. In 2021, Pierre Fabre gen-erated €2.5 billion in revenues, 65% of which came from in-ternational sales.  Manufacturing over 95% of its products in France, the Group employs some 10,000 people world-wide.  Its  products  are  distributed  in  116  countries.  Pierre  Fabre  is  86%-owned  by  the  Pierre  Fabre  Foundation,  a  government-recognised  public-interest  foundation,  and  secondarily by its own employees through an internation-al employee stock ownership plan. The company’s corpo-rate social and environmental responsibility approach has been assessed at the “Excellence” level by Ecocert Envi-ronnement in accordance with the ISO 26000 sustainable development standard.

Pfizer

Unifarco - Ceramol